Richardson PG, Hungria VTM, Yoon S-S, et al. Panobinostat plus bortezomib and dexamethasone in previously treated multiple myeloma: outcomes by prior treatment. Blood. 2016;127(6):713-721.

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2016
Materias:
Errata
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4929931/
https://www.ncbi.nlm.nih.gov/pubmed/31265499
http://dx.doi.org/10.1182/blood-2016-05-717777
_version_ 1782440676663754752
collection PubMed
description
format Online
Article
Text
id pubmed-4929931
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher American Society of Hematology
record_format MEDLINE/PubMed
spelling pubmed-49299312016-07-14 Richardson PG, Hungria VTM, Yoon S-S, et al. Panobinostat plus bortezomib and dexamethasone in previously treated multiple myeloma: outcomes by prior treatment. Blood. 2016;127(6):713-721. Blood Errata American Society of Hematology 2016-06-30 /pmc/articles/PMC4929931/ /pubmed/31265499 http://dx.doi.org/10.1182/blood-2016-05-717777 Text en © 2016 by The American Society of Hematology
spellingShingle Errata
Richardson PG, Hungria VTM, Yoon S-S, et al. Panobinostat plus bortezomib and dexamethasone in previously treated multiple myeloma: outcomes by prior treatment. Blood. 2016;127(6):713-721.
title Richardson PG, Hungria VTM, Yoon S-S, et al. Panobinostat plus bortezomib and dexamethasone in previously treated multiple myeloma: outcomes by prior treatment. Blood. 2016;127(6):713-721.
title_full Richardson PG, Hungria VTM, Yoon S-S, et al. Panobinostat plus bortezomib and dexamethasone in previously treated multiple myeloma: outcomes by prior treatment. Blood. 2016;127(6):713-721.
title_fullStr Richardson PG, Hungria VTM, Yoon S-S, et al. Panobinostat plus bortezomib and dexamethasone in previously treated multiple myeloma: outcomes by prior treatment. Blood. 2016;127(6):713-721.
title_full_unstemmed Richardson PG, Hungria VTM, Yoon S-S, et al. Panobinostat plus bortezomib and dexamethasone in previously treated multiple myeloma: outcomes by prior treatment. Blood. 2016;127(6):713-721.
title_short Richardson PG, Hungria VTM, Yoon S-S, et al. Panobinostat plus bortezomib and dexamethasone in previously treated multiple myeloma: outcomes by prior treatment. Blood. 2016;127(6):713-721.
title_sort richardson pg, hungria vtm, yoon s-s, et al. panobinostat plus bortezomib and dexamethasone in previously treated multiple myeloma: outcomes by prior treatment. blood. 2016;127(6):713-721.
topic Errata
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4929931/
https://www.ncbi.nlm.nih.gov/pubmed/31265499
http://dx.doi.org/10.1182/blood-2016-05-717777

Ejemplares similares